<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biosignaling.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Cell Communication and Signaling - Most accessed articles</title>
        <link>http://www.biosignaling.com</link>
        <description>The most accessed research articles published by Cell Communication and Signaling</description>
        <dc:date>2012-04-30T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/9/1/12" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/8/1/23" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/18" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/10/1/10" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/10/1/7" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/9/1/22" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/10/1/11" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/12" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/9/1/8" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/10/1/2" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biosignaling.com/content/9/1/12">
        <title>Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC</title>
        <description>The mesenchymal stroma harbors an important population of cells that possess stem cell-like characteristics including self renewal and differentiation capacities and can be derived from a variety of different sources. These multipotent mesenchymal stem cells (MSC) can be found in nearly all tissues and are mostly located in perivascular niches. MSC have migratory abilities and can secrete protective factors and act as a primary matrix for tissue regeneration during inflammation, tissue injuries and certain cancers.These functions underlie the important physiological roles of MSC and underscore a significant potential for the clinical use of distinct populations from the various tissues. MSC derived from different adult (adipose tissue, peripheral blood, bone marrow) and neonatal tissues (particular parts of the placenta and umbilical cord) are therefore compared in this mini-review with respect to their cell biological properties, surface marker expression and proliferative capacities. In addition, several MSC functions including in vitro and in vivo differentiation capacities within a variety of lineages and immune-modulatory properties are highlighted. Differences in the extracellular milieu such as the presence of interacting neighbouring cell populations, exposure to proteases or a hypoxic microenvironment contribute to functional developments within MSC populations originating from different tissues, and intracellular conditions such as the expression levels of certain micro RNAs can additionally balance MSC function and fate.</description>
        <link>http://www.biosignaling.com/content/9/1/12</link>
                <dc:creator>Ralf Hass</dc:creator>
                <dc:creator>Cornelia Kasper</dc:creator>
                <dc:creator>Stefanie Bohm</dc:creator>
                <dc:creator>Roland Jacobs</dc:creator>
                <dc:source>Cell Communication and Signaling 2011, null:12</dc:source>
        <dc:date>2011-05-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-9-12</dc:identifier>
                                <prism:require>/content/figures/1478-811X-9-12-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2011-05-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/8/1/23">
        <title>Rac and Rho GTPases in cancer cell motility control</title>
        <description>Rho GTPases represent a family of small GTP-binding proteins involved in cell cytoskeleton organization, migration, transcription, and proliferation. A common theme of these processes is a dynamic reorganization of actin cytoskeleton which has now emerged as a major switch control mainly carried out by Rho and Rac GTPase subfamilies, playing an acknowledged role in adaptation of cell motility to the microenvironment. Cells exhibit three distinct modes of migration when invading the 3 D environment. Collective motility leads to movement of cohorts of cells which maintain the adherens junctions and move by photolytic degradation of matrix barriers. Single cell mesenchymal-type movement is characterized by an elongated cellular shape and again requires extracellular proteolysis and integrin engagement. In addition it depends on Rac1-mediated cell polarization and lamellipodia formation. Conversely, in amoeboid movement cells have a rounded morphology, the movement is independent from proteases but requires high Rho GTPase to drive elevated levels of actomyosin contractility. These two modes of cell movement are interconvertible and several moving cells, including tumor cells, show an high degree of plasticity in motility styles shifting ad hoc between mesenchymal or amoeboid movements. This review will focus on the role of Rac and Rho small GTPases in cell motility and in the complex relationship driving the reciprocal control between Rac and Rho granting for the opportunistic motile behaviour of aggressive cancer cells. In addition we analyse the role of these GTPases in cancer progression and metastatic dissemination.</description>
        <link>http://www.biosignaling.com/content/8/1/23</link>
                <dc:creator>Matteo Parri</dc:creator>
                <dc:creator>Paola Chiarugi</dc:creator>
                <dc:source>Cell Communication and Signaling 2010, null:23</dc:source>
        <dc:date>2010-09-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-8-23</dc:identifier>
                                <prism:require>/content/figures/1478-811X-8-23-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2010-09-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/18">
        <title>Regulation of MicroRNA Biogenesis:
A miRiad of mechanisms
</title>
        <description>microRNAs are small, non-coding RNAs that influence diverse biological functions through the repression of target genes during normal development and pathological responses. Widespread use of microRNA arrays to profile microRNA expression has indicated that the levels of many microRNAs are altered during development and disease. These findings have prompted a great deal of investigation into the mechanism and function of microRNA-mediated repression. However, the mechanisms which govern the regulation of microRNA biogenesis and activity are just beginning to be uncovered. Following transcription, mature microRNA are generated through a series of coordinated processing events mediated by large protein complexes. It is increasingly clear that microRNA biogenesis does not proceed in a &apos;one-size-fits-all&apos; manner. Rather, individual classes of microRNAs are differentially regulated through the association of regulatory factors with the core microRNA biogenesis machinery. Here, we review the regulation of microRNA biogenesis and activity, with particular focus on mechanisms of post-transcriptional control. Further understanding of the regulation of microRNA biogenesis and activity will undoubtedly provide important insights into normal development as well as pathological conditions such as cardiovascular disease and cancer.</description>
        <link>http://www.biosignaling.com/content/7/1/18</link>
                <dc:creator>Brandi Davis</dc:creator>
                <dc:creator>Akiko Hata</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, null:18</dc:source>
        <dc:date>2009-08-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-18</dc:identifier>
                                <prism:require>/content/figures/1478-811X-7-18-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>18</prism:startingPage>
        <prism:publicationDate>2009-08-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/10/1/10">
        <title>Hybrid cells derived from breast epithelial cell/ breast cancer cell fusion events show a differential RAF-AKT crosstalk</title>
        <description>Background:
The biological phenomenon of cell fusion has been linked to several characteristics of tumour progression, including an enhanced metastatogenic capacity and an enhanced drug resistance of hybrid cells. We demonstrated recently that M13SV1-EGFP-Neo breast epithelial cells exhibiting stem cell characteristics spontaneously fused with MDA-MB-435-Hyg breast cancer cells, thereby giving rise to stable M13MDA435 hybrid cells, which are characterised by a unique gene expression profile and migratory behaviour. Here we investigated the involvement of the PLC-&#946;/&#947;1, PI3K/AKT and RAS-RAF-ERK signal transduction cascades in the EGF and SDF-1&#945; induced migration of two M13MDA435 hybrid cell clones in comparison to their parental cells.
Results:
Analysis of the migratory behaviour by using the three-dimensional collagen matrix migration assay showed that M13SV1-EGFP-Neo cells as well as M13MDA435 hybrid cells, but not the breast cancer cell line, responded to EGF stimulation with an increased locomotory activity. By contrast, SDF-1&#945; solely stimulated the migration of M13SV1-EGFP-Neo cells, whereas the migratory activity of the other cell lines was blocked. Analysis of signal transduction cascades revealed a putative differential RAF-AKT crosstalk in M13MDA435-1 and -3 hybrid cell clones. The PI3K inhibitor Ly294002 effectively blocked the EGF induced migration of M13MDA435-3 hybrid cells, whereas the EGF induced locomotion of M13MDA435-1 hybrid cells was markedly increased. Analysis of RAF-1 S259 phosphorylation, being a major mediator of the negative regulation of RAF-1 by AKT, showed decreased pRAF-1 S259 levels in LY294002 treated M13MDA435-1 hybrid cells. By contrast, pRAF-1 S259 levels remained unaltered in the other cell lines. Inhibition of PI3K/AKT signalling by Ly294002 relieves the AKT mediated phosphorylation of RAF-1, thereby restoring MAPK signalling.
Conclusions:
Here we show that hybrid cells could evolve exhibiting a differential active RAF-AKT crosstalk. Because PI3K/AKT signalling has been chosen as a target for anti-cancer therapies our data might point to a possible severe side effect of AKT targeted cancer therapies. Inhibition of PI3K/AKT signalling in RAF-AKT crosstalk positive cancer (hybrid) cells could result in a progression of these cells. Thus, not only the receptor (activation) status, but also the activation of signal transduction molecules should be analysed thoroughly prior to therapy.</description>
        <link>http://www.biosignaling.com/content/10/1/10</link>
                <dc:creator>Cem Ozel</dc:creator>
                <dc:creator>Jeanette Seidel</dc:creator>
                <dc:creator>Sonke Meyer-Staeckling</dc:creator>
                <dc:creator>Burkhard Brandt</dc:creator>
                <dc:creator>Bernd Niggemann</dc:creator>
                <dc:creator>Kurt Zanker</dc:creator>
                <dc:creator>Thomas Dittmar</dc:creator>
                <dc:source>Cell Communication and Signaling 2012, null:10</dc:source>
        <dc:date>2012-04-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-10-10</dc:identifier>
                                <prism:require>/content/figures/1478-811X-10-10-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2012-04-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/10/1/7">
        <title>The Incredible ULKs</title>
        <description>Macroautophagy (commonly abbreviated as autophagy) is an evolutionary conserved lysosome-directed vesicular trafficking pathway in eukaryotic cells that mediates the lysosomal degradation of intracellular components. The cytoplasmic cargo is initially enclosed by a specific double membrane vesicle, termed the autophagosome. By this means, autophagy either helps to remove damaged organelles, long-lived proteins and protein aggregates, or serves as a recycling mechanism for molecular building blocks. Autophagy was once invented by unicellular organisms to compensate the fluctuating external supply of nutrients. In higher eukaryotes, it is strongly enhanced under various stress conditions, such as nutrient and growth factor deprivation or DNA damage. The serine/threonine kinase Atg1 was the first identified autophagy-related gene (ATG) product in yeast. The corresponding nematode homolog UNC-51, however, has additional neuronal functions. Vertebrate genomes finally encode five closely related kinases, of which UNC-51-like kinase 1 (Ulk1) and Ulk2 are both involved in the regulation of autophagy and further neuron-specific vesicular trafficking processes. This review will mainly focus on the vertebrate Ulk1/2-Atg13-FIP200 protein complex, its function in autophagy initiation, its evolutionary descent from the yeast Atg1-Atg13-Atg17 complex, as well as the additional non-autophagic functions of its components. Since the rapid nutrient- and stress-dependent cellular responses are mainly mediated by serine/threonine phosphorylation, it will summarize our current knowledge about the relevant upstream signaling pathways and the altering phosphorylation status within this complex during autophagy induction.</description>
        <link>http://www.biosignaling.com/content/10/1/7</link>
                <dc:creator>Sebastian Alers</dc:creator>
                <dc:creator>Antje Loffler</dc:creator>
                <dc:creator>Sebastian Wesselborg</dc:creator>
                <dc:creator>Bjorn Stork</dc:creator>
                <dc:source>Cell Communication and Signaling 2012, null:7</dc:source>
        <dc:date>2012-03-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-10-7</dc:identifier>
                                <prism:require>/content/figures/1478-811X-10-7-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2012-03-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/9/1/22">
        <title>RACK1, A Multifaceted Scaffolding Protein: Structure and Function</title>
        <description>The Receptor for Activated C Kinase 1 (RACK1) is a member of the tryptophan-aspartate repeat (WD-repeat) family of proteins and shares significant homology to the &#946; subunit of G-proteins (G&#946;). RACK1 adopts a seven-bladed &#946;-propeller structure which facilitates protein binding. RACK1 has a significant role to play in shuttling proteins around the cell, anchoring proteins at particular locations and in stabilising protein activity. It interacts with the ribosomal machinery, with several cell surface receptors and with proteins in the nucleus. As a result, RACK1 is a key mediator of various pathways and contributes to numerous aspects of cellular function. Here, we discuss RACK1 gene and structure and its role in specific signaling pathways, and address how posttranslational modifications facilitate subcellular location and translocation of RACK1. This review condenses several recent studies suggesting a role for RACK1 in physiological processes such as development, cell migration, central nervous system (CN) function and circadian rhythm as well as reviewing the role of RACK1 in disease.</description>
        <link>http://www.biosignaling.com/content/9/1/22</link>
                <dc:creator>David Adams</dc:creator>
                <dc:creator>Dorit Ron</dc:creator>
                <dc:creator>Patrick Kiely</dc:creator>
                <dc:source>Cell Communication and Signaling 2011, null:22</dc:source>
        <dc:date>2011-10-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-9-22</dc:identifier>
                                <prism:require>/content/figures/1478-811X-9-22-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2011-10-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/10/1/11">
        <title>Meeting report: Signal transduction meets systems biology</title>
        <description>In the 21st century, systems-wide analyses of biological processes are getting more and more realistic. Especially for the in depth analysis of signal transduction pathways and networks, various approaches of systems biology are now successfully used. The EU FP7 large integrated project SYBILLA (Systems Biology of T-cell Activation in Health and Disease) coordinates such an endeavor. By using a combination of experimental data sets and computational modelling, the consortium strives for gaining a detailed and mechanistic understanding of signal transduction processes that govern T-cell activation. In order to foster the interaction between systems biologists and experimentally working groups, SYBILLA co-organized the 15th meeting &quot;Signal Transduction: Receptors, Mediators and Genes&quot; together with the Signal Transduction Society (STS). Thus, the annual STS conference, held from November 7 to 9, 2011 in Weimar, Germany, provided an interdisciplinary forum for research on signal transduction with a major focus on systems biology addressing signalling events in T-cells. Here we report on a selection of ongoing projects of SYBILLA and how they were discussed at this interdisciplinary conference.</description>
        <link>http://www.biosignaling.com/content/10/1/11</link>
                <dc:creator>Christine Louis-Dit-Sully</dc:creator>
                <dc:creator>Katharina Kubatzky</dc:creator>
                <dc:creator>Jonathan Lindquist</dc:creator>
                <dc:creator>Christine Blattner</dc:creator>
                <dc:creator>Ottmar Janssen</dc:creator>
                <dc:creator>Wolfgang Schamel</dc:creator>
                <dc:source>Cell Communication and Signaling 2012, null:11</dc:source>
        <dc:date>2012-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-10-11</dc:identifier>
                                <prism:require>/content/figures/1478-811X-10-11-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2012-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/12">
        <title>The receptor RAGE: Bridging inflammation and cancer</title>
        <description>The receptor for advanced glycation end products (RAGE) is a single transmembrane receptor of the immunoglobulin superfamily that is mainly expressed on immune cells, neurons, activated endothelial and vascular smooth muscle cells, bone forming cells, and a variety of cancer cells. RAGE is a multifunctional receptor that binds a broad repertoire of ligands and mediates responses to cell damage and stress conditions. It activates programs responsible for acute and chronic inflammation, and is implicated in a number of pathological diseases, including diabetic complications, stroke, atheriosclerosis, arthritis, and neurodegenerative disorders. The availability of Rage knockout mice has not only advanced our knowledge on signalling pathways within these pathophysiological conditions, but also on the functional importance of the receptor in processes of cancer. Here, we will summarize molecular mechanisms through which RAGE signalling contributes to the establishment of a pro-tumourigenic microenvironment. Moreover, we will review recent findings that provide genetic evidence for an important role of RAGE in bridging inflammation and cancer.</description>
        <link>http://www.biosignaling.com/content/7/1/12</link>
                <dc:creator>Astrid Riehl</dc:creator>
                <dc:creator>Julia Nemeth</dc:creator>
                <dc:creator>Peter Angel</dc:creator>
                <dc:creator>Jochen Hess</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, null:12</dc:source>
        <dc:date>2009-05-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-12</dc:identifier>
                                <prism:require>/content/figures/1478-811X-7-12-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-05-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/9/1/8">
        <title>A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells</title>
        <description>Embryonic stem cells (ESC) and induced pluripotent stem cells (iPSCs) present a great opportunity to treat and model human disease as a cell replacement therapy. There is a growing pressure to understand better the signal transduction pathways regulating pluripotency and self-renewal of these special cells in order to deliver a safe and reliable cell based therapy in the near future. Many signal transduction pathways converge on two major cell functions associated with self-renewal and pluripotency: control of the cell cycle and apoptosis, although a standard method is lacking across the field. Here we present a detailed protocol to assess the cell cycle and apoptosis of ESC and iPSCs as a single reference point offering an easy to use standard approach across the field.</description>
        <link>http://www.biosignaling.com/content/9/1/8</link>
                <dc:creator>Michael Edel</dc:creator>
                <dc:creator>Cristina Menchon</dc:creator>
                <dc:creator>Jose Miguel Andres Vacquero</dc:creator>
                <dc:creator>Juan Carlos Izpisua Belmonte</dc:creator>
                <dc:source>Cell Communication and Signaling 2011, null:8</dc:source>
        <dc:date>2011-04-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-9-8</dc:identifier>
                                <prism:require>/content/figures/1478-811X-9-8-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2011-04-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/10/1/2">
        <title>Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages</title>
        <description>Background:
Tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis (Mtb) remains a significant health problem worldwide with a third of the world population infected and nearly nine million new cases claiming 1.1 million deaths every year. The outcome following infection by Mtb is determined by a complex and dynamic host-pathogen interaction in which the phenotype of the pathogen and the immune status of the host play a role. However, the molecular mechanism by which Mtb strains induce different responses during intracellular infection of the host macrophage is not fully understood. To explore the early molecular events triggered upon Mtb infection of macrophages, we studied the transcriptional responses of murine bone marrow-derived macrophages (BMM) to infection with two clinical Mtb strains, CDC1551 and HN878. These strains have previously been shown to differ in their virulence/immunogenicity in the mouse and rabbit models of pulmonary TB.
Results:
In spite of similar intracellular growth rates, we observed that compared to HN878, infection by CDC1551 of BMM was associated with an increased global transcriptome, up-regulation of a specific early (6 hours) immune response network and significantly elevated nitric oxide production. In contrast, at 24 hours post-infection of BMM by HN878, more host genes involved in lipid metabolism, including cholesterol metabolism and prostaglandin synthesis were up-regulated, compared to infection with CDC1551.In association with the differences in the macrophage responses to infection with the 2 Mtb strains, intracellular CDC1551 expressed higher levels of stress response genes than did HN878.
Conclusions:
In association with the early and more robust macrophage activation, intracellular CDC1551 cells were exposed to a higher level of stress leading to increased up-regulation of the bacterial stress response genes. In contrast, sub-optimal activation of macrophages and induction of a dysregulated host cell lipid metabolism favored a less stressful intracellular environment for HN878. Our findings suggest that the ability of CDC1551 and HN878 to differentially activate macrophages during infection probably determines their ability to either resist host cell immunity and progress to active disease or to succumb to the host protective responses and be driven into a non-replicating latent state in rabbit lungs.</description>
        <link>http://www.biosignaling.com/content/10/1/2</link>
                <dc:creator>Mi-Sun Koo</dc:creator>
                <dc:creator>Selvakumar Subbian</dc:creator>
                <dc:creator>Gilla Kaplan</dc:creator>
                <dc:source>Cell Communication and Signaling 2012, null:2</dc:source>
        <dc:date>2012-01-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-10-2</dc:identifier>
                                <prism:require>/content/figures/1478-811X-10-2-toc.gif</prism:require>
                <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-01-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

